Literature DB >> 25974734

High Postnatal Growth Hormone Levels Are Related to Cognitive Deficits in a Group of Children Born Very Preterm.

Shannon E Scratch1, Peter J Anderson1, Lex W Doyle1, Deanne K Thompson1, Zohra M Ahmadzai1, Ronda F Greaves1, Terrie E Inder1, Rodney W Hunt1.   

Abstract

CONTEXT AND
OBJECTIVES: Little is known regarding the influence of GH on brain development, especially in infants born very preterm (VP; <30 weeks' gestation). Preterm infants are thought to have higher levels of GH in the first days of life compared with full-term infants. VP infants experience cognitive difficulties in childhood and have a diffuse pattern of structural brain abnormalities. This study aimed to explore the relationship between postnatal GH concentrations following VP birth and its association with cognitive functioning and brain volumes at age 7 years.
METHODS: Eighty-three infants born VP had GH concentrations measured at eight time points postnatally, and 2- and 6-week area under the curve (AUC) summary measures were calculated. Followup at age 7 years included neuropsychological assessment and brain magnetic resonance imaging. Univariable and multivariable regression modeling were used where AUC for GH was the main predictor of neurodevelopmental outcome at age 7 years.
RESULTS: Univariable modeling revealed that higher GH levels (2-week AUC) were related to poorer performance on a verbal working memory (P = .04) and shifting attention task (P = .01). These relationships persisted on multivariable modeling and when the 6-week AUC was analyzed; working memory (P = .03), immediate spatial memory (P = .02), and delayed spatial memory (P = .03) deficits were found. Higher GH levels were also associated with larger amygdala volumes after adjustment for potential confounders (P = .002, 2-week AUC; P = .03, 6-week AUC).
CONCLUSIONS: Higher postnatal GH levels may potentially contribute to the documented neurodevelopmental abnormalities seen in children born VP at school age.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25974734      PMCID: PMC4490305          DOI: 10.1210/jc.2014-4342

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysis.

Authors:  A C Burnett; P J Anderson; J Cheong; L W Doyle; C G Davey; S J Wood
Journal:  Psychol Med       Date:  2011-05-20       Impact factor: 7.723

2.  New MR imaging assessment tool to define brain abnormalities in very preterm infants at term.

Authors:  H Kidokoro; J J Neil; T E Inder
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-25       Impact factor: 3.825

Review 3.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

4.  Pediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000.

Authors:  Offie P Soldin; Eve G Hoffman; Michael A Waring; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

Review 5.  Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.

Authors:  R T Zoeller; J Rovet
Journal:  J Neuroendocrinol       Date:  2004-10       Impact factor: 3.627

Review 6.  Neural growth hormone: an update.

Authors:  Steve Harvey; Kerry Hull
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

7.  Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate.

Authors:  P Sytze van Dam; Channa F de Winter; Rehana de Vries; Jeroen van der Grond; Madeleine L Drent; Marijn Lijffijt; J Leon Kenemans; André Aleman; Edward H F de Haan; Hans P F Koppeschaar
Journal:  Psychoneuroendocrinology       Date:  2005-01-12       Impact factor: 4.905

8.  Rates of early intervention services in very preterm children with developmental disabilities at age 2 years.

Authors:  Gehan Roberts; Kelly Howard; Alicia J Spittle; Nisha C Brown; Peter J Anderson; Lex W Doyle
Journal:  J Paediatr Child Health       Date:  2007-11-12       Impact factor: 1.954

9.  Growth hormone, somatomedin C, and nonsuppressible insulin-like activity levels compared in premature, small, average birth weight, and large infants.

Authors:  N A Samaan; P N Schultz; D A Johnston; R W Creasy; B Gonik
Journal:  Am J Obstet Gynecol       Date:  1987-12       Impact factor: 8.661

10.  Educational outcomes in extremely preterm children: neuropsychological correlates and predictors of attainment.

Authors:  Samantha Johnson; Dieter Wolke; Enid Hennessy; Neil Marlow
Journal:  Dev Neuropsychol       Date:  2011       Impact factor: 2.253

View more
  1 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.